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Endothelial cells of initial lymphatics have discontinu-
ous button-like junctions (buttons), unlike continuous
zipper-like junctions (zippers) of collecting lymphatics
and blood vessels. Buttons are thought to act as primary
valves for fluid and cell entry into lymphatics. To learn
when and how buttons form during development and
whether they change in disease, we examined the appear-
ance of buttons in mouse embryos and their plasticity in
sustained inflammation.We found that endothelial cells of
lymph sacs at embryonic day (E)12.5 and tracheal lym-
phatics at E16.5 were joined by zippers, not buttons. How-
ever, zippers in initial lymphatics decreased rapidly just
before birth, as buttons appeared. The proportion of but-
tons increased from only 6% at E17.5 and 12% at E18.5 to
35% at birth, 50% at postnatal day (P)7, 90% at P28, and
100% at P70. In inflammation, zippers replaced buttons in
airway lymphatics at 14 and 28 days after Mycoplasma
pulmonis infection of the respiratory tract. The change in
lymphatic junctions was reversed by dexamethasone but
not by inhibition of vascular endothelial growth factor
receptor-3 signaling by antibody mF4-31C1. Dexametha-
sone also promoted button formation during early post-
natal development through a direct effect involving
glucocorticoid receptor phosphorylation in lymphatic en-
dothelial cells. These findingsdemonstrate theplasticity of
intercellular junctions in lymphatics during development
and inflammation and show that button formation can be
promoted by glucocorticoid receptor signaling in lym-
phatic endothelial cells. (Am J Pathol 2012, 180:2561–2575;
http://dx.doi.org/10.1016/j.ajpath.2012.02.019)
Lymphatic vessels have long served as transport routes
for extravasated fluid, antigens, and immune cells fromtissues to lymph nodes and then back into the blood-
stream.1–5 The understanding of this process has
evolved in stages. Lymphatics were found many years
ago to be sites of tracer uptake,6,7 but the entry mecha-
nism was unknown until electron microscopic studies in
the 1960s and 1970s revealed that lymphatic endothelial
cells have open junctions and are coupled to the extra-
cellular matrix by anchoring filaments.8,9 Elevated inter-
stitial fluid pressure is thought to open the junctions by
displacing anchoring filaments.
A subsequent refinement of the mechanism is the con-
cept of a two-valve system in lymphatics for unidirectional
entry and movement of fluid and cells.10 Primary valves in
the initial part of lymphatics regulate fluid and cell entry,
and secondary valves in collecting lymphatics prevent
backflow.10–12
The nature of the primary valves is incompletely under-
stood, even though the structure, function, and formation
of secondary valves are well characterized.6,10,13–19 The
discovery of discontinuous, button-like junctions (but-
tons) at the border of oak leaf–shaped endothelial cells of
initial lymphatics sheds light on the morphological basis
of primary valves.20,21 The unique structure of these junc-
tions, which are strikingly different from continuous zip-
per-like junctions (zippers) in other parts of lymphatics,
led to the concept that fluid and cells enter through flap-
covered openings between adjacent buttons.20 The route
of dendritic cell entry into lymphatics, viewed by live cell
imaging, is consistent with this concept.22,23
Little is known about how and when buttons form,
whether they change under conditions in which lymphatic
function is impaired, and whether the changes are re-
versible. A clue came from the finding that endothelial
cells of new lymphatics that grow at sites of inflammation
Supported by a postdoctoral fellowship award from the Lymphatic Re-
search Foundation (L.-C.Y.) and, in part, by grants from the National
Heart, Lung, and Blood Institute (HL-24136 and HL-59157 to D.M.M.).
Accepted for publication February 9, 2012.
Supplemental material for this article can be found at http://ajp.
amjpathol.org or at http://dx.doi.org/10.1016/j.ajpath.2012.02.019.
Address reprint requests to Donald M. McDonald, M.D., Ph.D., Depart-
ment of Anatomy, University of California, 513 Parnassus Ave., Room
S1349, San Francisco, CA 94143-0452. E-mail: donald.mcdonald@
ucsf.edu.
2561
2562 Yao et al
AJP June 2012, Vol. 180, No. 6are joined by zippers instead of buttons.20 If growth or
remodeling of lymphatics in inflamed tissues is accompa-
nied by loss of primary valves and appearance of continu-
ous junctions that are less permeable, the changes could
impair fluid entry and drainage. In airway inflammation, this
impairment could contribute to mucosal edema and airflow
obstruction, which are common features.24,25 Although
edema commonly results from vascular leakage,26,27 im-
paired fluid clearance through lymphatics would amplify
any mismatch between the amounts of leakage and
clearance.28–35
With this background, we sought to learn how and when
buttons form in lymphatics during development, to explore
the plasticity of buttons in inflammation, and to determine
the reversibility of the inflammatory changes. In particular,
we asked whether buttons form de novo as lymphatics de-
velop, whether buttons transform into zippers in inflamma-
tion, and whether the transformation is reversible.
We examined the development of lymphatic endothelial
junctions in lymph sacs and in lymphatic vessels in mouse
airways and diaphragms from E12.5 to birth and into adult-
hood.36,37 We also examined the changes in lymphatic
junctions in inflamed airways after Mycoplasma pulmonis
infection,20 where lymphangiogenesis is a prominent fea-
ture.29 We tested the reversibility of changes in lymphatic
junctions after infection by using dexamethasone to reverse
the inflammatory response to M. pulmonis infection38,39 or
by blocking vascular endothelial growth factor receptor
(VEGFR)-3 signaling to suppress lymphatic growth.29 Fi-
nally, we determined whether dexamethasone can promote
button formation through direct effects on glucocorticoid
receptor (GR) activation in lymphatic endothelial cells of
neonatal mice in the absence of inflammation.40
We found that zippers were present at E12.5 and pre-
ceded the appearance of buttons in lymphatics during
development. Transformation from exclusively zippers to
predominately buttons began at E17.5, progressed rap-
idly at birth, and was 90% complete at P28. Buttons
reverted into zippers in sustained inflammation, but treat-
ment with dexamethasone promoted the reappearance
of buttons. Dexamethasone also advanced button forma-
tion during early postnatal development through a direct
effect on lymphatic endothelial cells.
Materials and Methods
Mice
C57BL/6 mice (Charles River, Hollister, CA) of either sex
were housed under barrier conditions until they were stud-
ied at the desired age. FVB/N mice from the same vendor
were bred, and neonates were used in some experiments,
as described. Embryonic age was counted from the day of
vaginal plug discovery, E0.5. In studies of inflammation,
pathogen-free, 8-week-old, female C57BL/6 mice were
housed under barrier conditions before and afterM. pulmo-
nis infection. The Institutional Animal Care and Use Com-
mittees of the University of California at San Francisco ap-
proved all experimental procedures.M. pulmonis Infection
The C57BL/6 mice were briefly anesthetized (ketamine,
83 mg/kg, and xylazine, 13 mg/kg, by i.m. injection) and
then were infected by intranasal inoculation of 50 L of
broth containing 106 colony-forming units of M. pulmonis
organisms of strain CT7.29 From 7 to 28 days after infec-
tion, mice were anesthetized and perfused through the
heart with 1% paraformaldehyde (PFA) fixative in PBS
(pH 7.4). The tracheas, lungs, and bronchial lymph
nodes were removed. The wet weights of lungs and bron-
chial lymph nodes, expressed as a percentage of final
body weight, were used to estimate disease severity.
Dexamethasone Treatment
Adult C57BL/6 mice received dexamethasone (10 mg/kg,
i.p.; Phoenix Pharmaceuticals Inc., Belmont, CA) or the
same volume of sterile 0.9% NaCl (vehicle)39 once daily
on days 14 through 28 after infection. Newborn C57BL/6
or FVB/N mice (P0) received dexamethasone daily (1
mg/kg, s.c.)41 or no treatment for 4 days.
Inhibition of VEGFR-3 Signaling
Function-blocking, rat monoclonal anti-VEGFR-3 anti-
body (clone mF4-31C1; ImClone Systems, Inc., New
York, NY) was injected i.p. into 8-week-old, pathogen-
free or infected C57BL/6 mice at an initial dose of 2 mg
per mouse and then 0.8 mg per mouse every other day
for 14 days.29 In the infected mice, the 14-day treatment
began 14 days after infection. PBS was used as a control
(vehicle) to treat infected or pathogen-free mice.
IHC Data
Pregnant females were anesthetized (ketamine, 83 mg/
kg, and xylazine, 13 mg/kg, i.m.) at timed gestation, and
the uterus was opened. E12.5 embryos were removed
and fixed by immersion in 4% PFA in PBS at room tem-
perature for 2 hours, cryoprotected with 30% sucrose in
PBS, and embedded in Tissue-Tek optimal cutting tem-
perature (OCT) compound (Sakura Finetek, Torrance,
CA).42 Older embryos were euthanized by immersion in
ice-cold PBS for 30 minutes without exposure to room air,
and then the trachea, lung, and diaphragm were re-
moved in PBS and fixed by immersion in 1% PFA in PBS
at room temperature for 1 hour.43 Mice at P0 and older
were anesthetized by injection of the same anesthetic,
and the vasculature was fixed by systemic vascular per-
fusion of 1% PFA in PBS for 2 minutes, followed by im-
mersion of the trachea and diaphragm in the same fixa-
tive at room temperature for 1 hour.43 For ease of making
flat whole mounts, the trachea of mice at E16.5 to P7 was
cut along the dorsal longitudinal axis; the trachea from
adult mice was cut along the ventral longitudinal axis.
Tissue whole mounts or cryostat sections (60-m
thick) were stained by immunohistochemical (IHC) pro-
cedures previously described,43 using the following
primary antibodies. For intercellular junctions, we used
VE-cadherin [rat anti-mouse, clone 11D4.1 (BD Biosci-
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Santa Cruz, CA) was used for tissues from mice treated
with the rat anti-VEGFR-3 antibody, in which the anti-rat
secondary antibody gave strong background staining];
-catenin (rabbit polyclonal; Sigma-Aldrich, St. Louis,
MO); p120-catenin (rabbit anti-mouse, clone E205; Epito-
mics, Burlingame, CA); and zonula occludens protein 1
(ZO-1), occludin, and/or claudin-5 (rabbit polyclonal; In-
vitrogen, Carlsbad, CA). For lymphatics, we used lym-
phatic vessel endothelial cell receptor (LYVE)-1 [rabbit
polyclonal (AngioBio, Del Mar, CA) or goat polyclonal
(R&D, Minneapolis, MN)], Prox1 [rabbit polyclonal
(AngioBio) or goat polyclonal (R&D)], and/or podoplanin
(Syrian hamster anti-mouse, clone 8.1.1; eBioscience,
San Diego, CA). For activated GR, we used phosphoryl-
ated (phospho)-GR (Ser211, rabbit polyclonal; Cell Sig-
naling, Danvers, MA). Primary antibodies were identified
by secondary antibodies labeled with fluorescein isothio-
cyanate, Cy3, or Cy5 (Jackson ImmunoResearch, West
Grove, PA). Specimens were viewed with a Zeiss Axio-
phot fluorescence microscope or a Zeiss LSM-510 con-
focal microscope (Carl Zeiss, Oberkochen, Germany) us-
ing AIM 4.0 confocal software (Carl Zeiss).
Morphometric Measurements
Lymphatics in whole mounts of trachea and diaphragm
were measured in real-time images by using a digitizing
tablet linked to a video camera on a Zeiss Axiophot
microscope. For the quantitative studies, buttons were
defined as distinct, discontinuous segments of VE-cad-
herin immunoreactivity at the border of endothelial cells
of initial lymphatics. Zippers were defined as distinct,
continuous lines of VE-cadherin at cell borders. Junctions
that were not clearly recognized as either buttons or
zippers were designated intermediate junctions.
The number of VE-cadherin–stained buttons per 1000-
m2 projected area of LYVE-1–stained lymphatic vessel
surface was measured at a final screen magnification of
1520 (surface density of buttons). In the trachea, one
lymphatic was measured in each of 5 to 10 spaces be-
tween cartilage rings, beginning at the rostral end near
the larynx. In the diaphragm, 5 to 10 lymphatics in the
central tendon were measured. Embryonic data were
obtained from two or more litters.
Age-related changes in the proportions of zippers, but-
tons, and intermediate junctions (proportion of total junc-
tions) were assessed by examining the frequency of each
junctional type in tracheal lymphatics from E16.5 to adult
(P70). Measurements of the surface density of buttons
were used as the reference at each age, and the total
amount of junctional length per cell was considered
100%. The size and perimeter of lymphatic endothelial
cells were relatively constant.
For the time course of zipper-to-button transformation
after infection, we examined 5 to 10 regions of the tra-
chea of each of five mice per group after 7, 14, or 28 days
of infection. Sprouts and stalks of new lymphatics were
measured over cartilage rings, where none are present
normally; and existing lymphatics were measured be-
tween cartilage rings, where lymphatics are normally lo-cated. The area density of LYVE-1–positive vessels was
measured by stereological point counting at a final
screen magnification of 96029 in regions of mucosa over
cartilage rings (one region per ring; 10 rings per mouse),
where the changes during infection were greatest.
Statistical Analysis
Values are presented asmean SEM, with 5 to 10mice per
group. Differences betweenmeans were assessed by anal-
ysis of variance, followed by the Bonferroni test for multiple
comparisons. P  0.05 was considered significant.
Results
Zippers between Endothelial Cells of Primitive
Lymphatic Structures at E12.5
Jugular lymph sacs are primitive lymphatic structures that
derive from a population of Prox1-expressing cells of the
anterior cardinal vein and produce lymphatic vessels.44 To
determine whether intercellular junctions are present and
specifically whether buttons are present when lymphatics
form, we examined Prox1-positive cells in the anterior car-
dinal vein, jugular lymph sacs, and neighboring lymphatic
structures (Figure 1, A–D). At E12.5, Prox1 cells budding
from the anterior cardinal vein were joined exclusively by
zippers, which were identified as continuous lines of VE-
cadherin immunoreactivity at cell borders (Figure 1B). No
buttons were found. Similarly, Prox1 cells in jugular lymph
sacs and adjacent lymphatic structures had zippers (Figure
1, C and D). Small clusters of apparently migrating Prox1
cells (Figure 1, E and F) were also joined by zippers similar
to those in growing blood vessels (Figure 1G). More than
90% of Prox1 cells examined in cross sections of E12.5
embryos were interconnected by zippers marked by VE-
cadherin immunoreactivity.
The trachea and lungs develop by growth and branching
of endodermal epithelium into the surrounding mesen-
chyme around E11 in themouse.45 An examination of whole
mounts of trachea and lung at E12.5 revealed that the
primary blood vascular network was already established in
the lungs and formed a primitive plexus in the trachea
(Figure 1H). Prox1 cells were abundant in the trachea and
were arranged in primitive networks, unlike the segmental
pattern at birth and beyond. Prox1 cells in the lung were
distributed along the main stem and secondary bronchi. At
this early stage, tracheal lymphatics and some blood ves-
sels had VEGFR-3 immunoreactivity, but LYVE-1 staining
was faint or absent (data not shown). Endothelial cells of the
tracheal lymphatic plexus had zippers, shown by VE-cad-
herin staining, but no buttons (Figure 1, I and J).
Zipper-to-Button Transformation in Initial
Lymphatics around Birth
The tracheal mucosa of adult mice has a distinctive seg-
mental arrangement of lymphatics, which are restricted to
regions between cartilage rings and are largely absent over
the cartilage rings.20,39 Unlike the primitive plexus at E12.5,
tracheal lymphatics at E16.5 had a segmental pattern of
2564 Yao et al
AJP June 2012, Vol. 180, No. 6Figure 1. Zipper-like junctions in primitive lymphatic endothelium at E12.5. A: Low-magnification view of Prox1-immunoreactive endothelial cell nuclei
(green) in a cross section of embryo at E12.5 showing the anterior cardinal vein (CV), jugular lymph sac (JLS), and tissue near the JLS. Boxed regions in
A are enlarged in B–D. B–D: Endothelial cells joined by zippers (arrows) in lymphatic structures stained for Prox1 (green) and podoplanin (blue) are
shown next to the cardinal vein (B), within the JLS (C), and in adjacent tissue (D). E and F: Zippers (arrows) in a cluster of Prox1-positive endothelial
cells. G: Zippers (arrow) in the endothelium of a blood vessel (Prox1 negative) at E12.5. H–J: Whole mount of trachea and lungs at E12.5 showing zippers
in the endothelium (VE-cadherin, red) of blood vessels and lymphatics and nuclei of lymphatic endothelial cells (Prox1, green). Arrows, main stem
bronchi. The boxed region in H is enlarged in I to show the primitive lymphatic plexus in the trachea. The boxed region in I is enlarged in J, as well as
a small region outside the field of view, to show zippers in the endothelium of lymphatics at E12.5 (J: arrows). Scale bars: 200 m (A); 50 m (B, D, and
I); 20 m (C, E–G, and J); 400 m (H).
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lymphatics at E16.5 resembled the adult pattern but had
little branching (Figure 2A), and the endothelial cells were
joined by zippers (Figure 2A), not buttons.
Buttons, identified as segments of VE-cadherin stain-
ing, which appeared to be oriented perpendicular to the
endothelial cell border, were first detected in tracheal
lymphatics at E17.5 and became more abundant there-
after (Figure 2, B–L). Measurements made to determine
the rate of appearance of buttons during the develop-
ment of tracheal lymphatics revealed that the relative
frequency of buttons was 6% at E17.5, 12% at E18.5,
35% at birth (P0), 50% at P7, 62.5% at P14, and 90% at
P28; the number of buttons per initial lymphatic in the
adult (P70) served as the reference (Figure 2B).
To determine whether values from the trachea applied
to other organs, we measured the appearance of buttons
in initial lymphatics of the diaphragm20 and obtained
relatively similar values. Compared with values in the
adult, buttons in diaphragmatic lymphatics had a fre-
quency of 1% at E17.5, 4% at E18.5, 20% at P0, 50% at
P7, 60% at P14, and 81% at P28 (Figure 2B). During the
day of birth, between E18.5 and P0, buttons became twice
as abundant in the trachea and four times as numerous in
the diaphragm. Zippers in the endothelium of collecting
lymphatics were unchanged during this period.
A more detailed examination of the apparent transfor-
mation of zippers into buttons revealed that the junctions
between lymphatic endothelial cells could not meaning-
fully be divided into only two distinct categories. Interme-
diate forms were present (Figure 2, C–L). We divided the
process of button formation into four stages (Figure 2,
D–L). First, from E17.5 to E18.5, VE-cadherin at cell bor-
ders changed conspicuously from uniform lines to lines
with alternating thick and thin regions (Figure 2, D and I).
Second, from P0 through P7, some cell junctions ap-
peared fragmented, whereas others did not appear frag-
mented; most cell borders were smooth (Figure 2, E and
J). Third, from P7 to P14, buttons were more distinct, the
border of some cells was scalloped, and the cells had an
oak leaf shape (Figure 2, F and K). The apparent perpen-
dicular orientation of buttons coincided with the appear-
ance of the scalloped border of oak leaf–shaped en-
dothelial cells. Fourth, after P14, buttons marked by
VE-cadherin staining had the distinctive adult pattern,
and the endothelial cells of most initial lymphatics were
oak leaf shaped (Figure 2, G and L). At three-cell junc-
tions, buttons had a distinctive three-part structure re-
sembling a three-bladed propeller (Figure 2, G and L).
The stages were similar in the trachea and diaphragm
but were easier to analyze in the diaphragm. Buttons
counted in Figure 2B were distinctly segmented junc-
tions. Intermediate forms of junctions were the most prev-
alent type from P0 through P14 but were counted as
buttons only if they had distinct button-like segments.
During this period, changes in the distribution of
LYVE-1 in lymphatic endothelial cells coincided with
changes in VE-cadherin. At E16.5, LYVE-1 immunoreac-
tivity was uniformly spread over the surface of endothelial
cells (Figure 2H). From E17.5 to E18.5, some LYVE-1 was
dispersed and some was concentrated at cell borders(Figure 2I). From P0 through P7, LYVE-1 was consistently
more concentrated near buttons (Figure 2J). From P7 to
P14, LYVE-1 was strong at cell borders, where it was
located between buttons and had a complementary dis-
tribution to VE-cadherin (Figure 2K). After P14, the com-
plementary patterns of LYVE-1 and VE-cadherin high-
lighted the distinctive oak leaf shape of endothelial cells
of initial lymphatics in the adult (Figure 2L).20,46
To compare the age-related changes in zippers, inter-
mediate junctions, and buttons, we estimated the propor-
tions of each type of junction in the trachea from E16.5 to
P70 (Figure 2M). The incidence of zippers decreased
steeply just before birth to only 20% of the value at E16.5.
Intermediate junctions increased rapidly just before birth
and then gradually decreased during the next four weeks
as they transformed into buttons. Buttons appeared just
before birth, but at P0, they represented only about 30%
of the eventual number in initial lymphatics at P70. Even
at P70, approximately 5% of the junctions in initial lym-
phatics had the form of zippers or intermediate junctions.
Junctional Proteins in Lymphatic Endothelial
Cells at Different Developmental Stages
With evidence that VE-cadherin is a consistent feature of
endothelial cell junctions in lymphatics throughout devel-
opment and in the adult,20,47 we sought to determine
whether other junctional proteins make similarly constant
contributions as zippers transform into buttons. We found
that the intensity of IHC staining for the tight junction
proteins claudin-5, occludin, and ZO-1 (an intracellular
partner that interacts with the actin cytoskeleton) was
similar at E17.5, P0, and P28 in zippers, buttons, and
intermediate-type junctions (see Supplemental Figures
S1 and S2 at http://ajp.amjpathol.org).20,47 The intracellu-
lar proteins -catenin and p120-catenin, which play an
important role in stabilizing endothelial cell-cell adhesion
by linking VE-cadherin to the actin cytoskeleton,47 colo-
calized with VE-cadherin at E17.5 and P0 in all three
types of junctions (Figure 3, A–H).
Button-to-Zipper Transformation in Lymphatics
after M. pulmonis Infection
To build on evidence that zippers predominate in grow-
ing sprouts from initial lymphatics at sites of inflamma-
tion,20 we asked whether all newly formed lymphatics
have zippers, as in early development, or whether this
change is a manifestation of the transformation of buttons
to zippers in a pathological setting. Our approach was to
compare the distribution of buttons and zippers in tra-
cheal lymphatics after M. pulmonis infection for 7, 14, or
28 days, with that present normally.
In tracheas of pathogen-free adults, lymphatics were
restricted to regions of mucosa between cartilage rings
(Figure 4A). As previously reported,20 buttons identified
by discontinuous VE-cadherin immunoreactivity at the
scalloped border of lymphatic endothelial cells were
present in 100% of initial lymphatics (Figure 4B), but not
in collecting lymphatics, which had zippers (Figure 4C).
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AJP June 2012, Vol. 180, No. 6Figure 2. Development of button-like junctions in the endothelium of lymphatics. A: Lymphatic vascular plexus (LYVE-1, green) in a tracheal whole mount at
E16.5, showing tips of initial lymphatics (long arrows). Inset: Zipper-like junctions (VE-cadherin, red) in lymphatic endothelium (short arrows). Most of the
lymphatics are located between cartilage rings (asterisks). B: Time course of development of button-like junctions in lymphatics of trachea (red) and diaphragm
(blue) from E16.5 to P70. Buttons are expressed as number of adult-like VE-cadherin–stained segments. Buttons that appear before birth represent only
approximately 35% and 20% of the eventual number present in adult (P70) initial lymphatics of trachea and diaphragm, respectively. *P  0.05, values at P0
(arrow) are significantly different from those at E18.5. C–L: Lymphatic endothelial cell junctions are shown as inverted gray scale images (C–G: VE-cadherin) and
in color (H–L: VE-cadherin, red; LYVE-1, green) to illustrate the sequence of changes in zipper-to-button transformation from E16.5 to P70 (diaphragm). Zippers
are also shown in a blood vessel at E16.5 (C and H: long arrow). At P70, a distinctive structure at the junction of three lymphatic endothelial cells with button-like
junctions is indicated by circles (G and L). M: Changes of tracheal lymphatic junction phenotype from E16.5 to P70, including zippers (green), intermediate (light
blue), and buttons (red). Scale bars: 100 m (A); 10 m (C–L).
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at 7 days and were abundant at 14 days (Figure 4D).
Lymphatic sprouts were readily identified in regions over
cartilage rings, because no lymphatics were normally
present. At 7 days, zippers were present in lymphatic
sprouts over the rings, suggesting that they were present
as the sprouts grew. Buttons still predominated in initial
lymphatics between the rings at 7 days, but 50% of these
lymphatics had zippers at 14 days and 75% had zippers
at 28 days, indicating that zippers gradually replaced
buttons in the existing initial lymphatics.
Staining of lymphatic sprouts for the tight junction protein
claudin-5 after 14 days of infection gave essentially the
same number and distribution of zippers as did staining for
VE-cadherin (Figure 4, E and F). The same was found for
zippers in other regions of initial lymphatics, where buttons
would normally be found (Figure 4, G–I). This feature of the
junctional composition of zippers after infection resembled
Figure 3. Colocalization of -catenin and p120-catenin with VE-cadherin at lym
showing colocalization of -catenin (A–D) or p120-catenin (E–H) (red) and VE
D, G, and H). Junctions in tracheal lymphatics had clear VE-cadherin immunore
and H reflects the colocalization of VE-cadherin (green) and -catenin or p120that observed under normal conditions.Reversal of Button-to-Zipper Transformation in
Infected Airways
Because buttons appeared to transform into zippers after
infection, we asked whether the process was reversible.
We used two approaches. First, we determined whether
the zippers could be reverted to buttons by reducing the
inflammation by treatment with dexamethasone, which
decreases the severity of M. pulmonis infection and re-
duces VEGFR-3 expression in infected airways.29,39 Sec-
ond, we reduced VEGF-C–mediated lymphangiogenesis
after infection by treatment with the function-blocking
anti-VEGFR-3 antibody mF4-31C1.29,39
Treatment of adult mice with dexamethasone for 14
days was started after infection was established for 14
days, when new lymphatics were abundant in the tra-
chea. As previously reported,29,39 dexamethasone treat-
ndothelial cell junctions at E17.5 and P0. Confocal images of tracheal lymphatics
n (green) at zippers at E17.5 (A, B, E, and F) and at primitive buttons at P0 (C,
t E17.5 and P0, albeit weaker than in blood vessels. Yellow staining in B, D, F,
(red) at junctions in lymphatic vessels. Scale bar  10 m.phatic e
-cadheriment stopped further lymphangiogenesis but did not
uts (E a
row). S
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cartilage rings (Figure 5A). As a measure of disease
severity, the treatment reduced by 85% the 22-fold
weight gain of bronchial lymph nodes and reduced by
53% the threefold weight gain of lungs at 28 days after
infection (Figure 5B).
In contrast to tracheas of mice infected for 28 days
without treatment, in which zippers were abundant in
lymphatics (Figure 5, C–E), buttons predominated in lym-
Figure 4. Transformation of buttons to zippers in lymphatics after M. p
pathogen-free or M. pulmonis–infected mice. A–C: Different distributions of
trachea. Regions of mucosa over cartilage rings (asterisks) are almost fre
distributions at buttons in initial lymphatics (B), but LYVE-1 is weak or ab
immunoreactivity (C: short arrows). D–I: Zippers in lymphatic endothelium
LYVE-1 (D, E, G, and I) or claudin-5 (F and H) (green). Network of new or re
in E–H to show zippers. E–I: Zippers (long arrows) in tips of lymphatic spro
initial lymphatics (I). Claudin-5 is weak in blood vessels (E and F: short arphatics of infected mice treated with dexamethasone forthe final 14 days (Figure 5, F–H). Similar effects of dexa-
methasone were found on the distribution of LYVE-1 in
lymphatic endothelial cells. The uniform distribution of
LYVE-1 staining in lymphatics after infection changed after
dexamethasone into a pattern in which staining was con-
centrated at endothelial cell borders at sites between VE-
cadherin–stained buttons (Figure 5, F–H). These effects of
dexamethasone were consistent with promotion of button
formation, redistribution of LYVE-1, and recovery of the oak
s infection. Confocal images of lymphatics in tracheal whole mounts of
tics (LYVE-1, green) and blood vessels (VE-cadherin, red) in pathogen-free
phatics (A). VE-cadherin (red) and LYVE-1 (green) have complementary
collecting lymphatics (C). Some extracellular leukocytes also have LYVE-1
after M. pulmonis infection (14 days) by staining for VE-cadherin (red) and
d lymphatics above a cartilage ring (D). The boxed regions in D are enlarged
nd F), stalks of lymphatic sprouts (G and H), and other regions of remodeled
cale bars: 200 m (A); 50 m (D); 20 m (B, C, and E–I).ulmoni
lympha
e of lym
sent in
shown
modeleleaf phenotype of lymphatic endothelial cells.
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AJP June 2012, Vol. 180, No. 6Figure 5. Reversal of button-to-zipper conversion in inflamed airways. A and B: Lymphatic area density in mucosa overlying cartilage rings (A) and normalized
bronchial lymph node and lung weights (B). *P  0.05 versus pathogen-free mice; †P  0.05 versus the 14-day infected baseline group. Dex, dexamethasone.
C–E: Zippers in lymphatic endothelium shown after M. pulmonis infection and vehicle treatment by staining for VE-cadherin (red) and LYVE-1 (green).
Enlargement of boxed regions in C shows zippers (arrows) in both new (D) and existing (E) lymphatics. F–H: Buttons in nonregressed lymphatic endothelium
shown after M. pulmonis infection and Dex treatment. Enlargement of boxed regions in F shows buttons (arrows) in the oak leaf–shaped endothelial cells of
new (G) and existing (H) lymphatics. I–K: Zippers (arrows) in lymphatic endothelium shown after M. pulmonis infection and anti-VEGFR-3 antibody treatment.
Enlargement of boxed regions in I shows zippers (arrows) in both new (J) and existing (K) lymphatics. Scale bars: 50 m (C, F, and I); 20 m (D, E, G, H, J,
and K).
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driven by VEGFR-3 signaling, we blocked VEGFR-3 signal-
ing with the antibody mF4-31C1 from day 14 to 28 after
infection of adult mice. This treatment prevented further
lymphangiogenesis but did not reduce the density of tra-
cheal lymphatics to less than the amount present at the
onset of treatment (Figure 5A) and did not block the infec-
tion-related weight gain of bronchial lymph nodes and lungs
(Figure 5B). Unlike dexamethasone, mF4-31C1 treatment
didnot reduce theproportionof zippers in lymphatic sprouts or
stalks (Figure 5, I–K). Control experiments in tracheas of
8-week-old pathogen-free mice showed that mF4-31C1 for 2
weeks did not alter the number or appearance of buttons in
normal initial lymphatics (data not shown).
Promotion by Dexamethasone of Zipper-to-
Button Transformation in Neonatal Airways
Next, we examined the question of whether the promotion
of zipper-to-button conversion by dexamethasone results
from anti-inflammatory actions of dexamethasone or from
a direct effect on lymphatics. These experiments ex-
ploited the natural zipper-to-button transformation that
occurs in neonatal airways from P0 to P4. The approach
was to determine whether dexamethasone accelerated
this natural transformation in neonates.
We found that the overall organization of lymphatics in
the trachea of mice treated with dexamethasone from P0 to
P4 was similar to that of nontreated littermates (Figure 6, A
and B). However, individual lymphatics after dexameth-
asone had striking differences from the nontreated con-
trols. In healthy neonates at P4, most junctions in initial
lymphatics were intermediate between zippers and but-
tons, except for lymphatic sprouts, where zippers pre-
dominated (Figure 6, A, C, and D); lymphatic endothelial
cells had an irregular shape and a uniform distribution of
LYVE-1 (Figure 6, A and D). In contrast, initial lymphatics
in dexamethasone-treated neonates at P4 had lymphat-
ics with ubiquitous buttons resembling those in the adult
(Figure 6E) and few intermediate junctions. The lymphat-
ics were wider, had more rounded ends, and had few
sprouts or zippers (Figure 6B). The endothelial cells of
these lymphatics were oak leaf shaped, and the distribu-
tion of LYVE-1 was complementary to the pattern of VE-
cadherin in buttons (Figure 6E). The same results were
obtained in a repeat experiment using neonates of the
FVB/N background (data not shown).
The promotion of button formation by dexamethasone
was restricted to initial lymphatics. Collecting lymphatics,
identified by the presence of intraluminal valves, had only
zippers (Figure 6, F and G). Also, after dexamethasone,
the endothelium of the thoracic duct had only zippers
(Figure 6, H and I), albeit the endothelial cell borders
were more jagged than those in the controls.
Activation of GRs in Lymphatic Endothelial Cells
To further explore whether dexamethasone promotes but-
ton formation in neonates by acting directly on lymphatics,
we determined whether lymphatic endothelial cells haveGRs and whether dexamethasone activates the receptors.
Neonatal C57BL/6 mice were treated with dexamethasone
from P0 to P4, and activated GR immunoreactivity was
assessed in tracheal lymphatics using an antibody to phos-
pho-GR (Ser211), which accumulates in the nucleus after
ligand binding.48 In untreated neonates at P4, many cell
types, including Prox1-positive cells of lymphatics, had de-
tectable nuclear phospho-GR immunoreactivity, but the in-
tensity was variable, and staining was faint in lymphatics
with zippers (Figure 7, A and B). However, after dexameth-
asone, phospho-GR immunoreactivity was uniformly stron-
ger in Prox1-positive nuclei of lymphatic endothelial cells
that had buttons (Figure 7, C and D). No nuclear staining
was present when the phospho-GR primary antibody was
omitted (Figure 7, E and F).
Discussion
This study revealed a previously unrecognized plasticity
of intercellular junctions in the endothelium of the initial
part of lymphatics, where fluid and cell entry is thought to
occur. Zippers transformed into buttons during develop-
ment, and buttons transformed into zippers in inflamma-
tion. When the lymphatic network of the mouse trachea was
established at E16.5, only zippers were present. Similar
junctions were present in jugular lymph sacs and in the
primitive lymphatic plexus of the trachea at E12.5. Zippers
began to be replaced by buttons at E17.5. This transforma-
tion was rapid at birth and largely complete by P28. No
change was found in the composition of the junctional pro-
teins during this transformation. In sustained inflammation
afterM. pulmonis infection, zippers had replaced buttons in
existing initial lymphatics by 14 to 28 days. Treatment
with dexamethasone reversed the junctional change in
inflammation and promoted button formation in neonatal
lymphatics. Dexamethasone caused the accumulation of
phosphorylated GRs in the nucleus of lymphatic endo-
thelial cells, consistent with a direct action on these cells.
Changes in Lymphatic Endothelial Cell
Junctions during Development
The endothelial cells of lymphatic sacs and other primitive
lymphatic structures present at E12.5 were joined by zip-
pers. Buttons were not found until late gestation. Most lym-
phatic endothelial cells identified by Prox1 staining at E12.5
were joined by zippers and were part of multicellular lym-
phatic sprouts, rather than separate migrating cells.
Several lines of evidence from studies of developing
lymphatics were consistent with the concept that buttons
form from zippers via intermediate junctional forms. First,
zippers, buttons, and intermediate junctions were com-
posed of the same proteins. Second, zippers preceded
the appearance of buttons in development. Third, the
number of zippers decreased sharply just before birth,
precisely when buttons appeared. Fourth, intermediate
junctional forms resembled fragmented zippers and were
most numerous as buttons increased in abundance around
birth, but they were rare in the adult. Fifth, the gradual
increase in buttons during the first 4 weeks after birth coin-
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AJP June 2012, Vol. 180, No. 6Figure 6. Promotion of button formation in neonatal lymphatics by dexamethasone. A and B: Lymphatics (LYVE-1, green) in tracheal whole mounts of untreated
(A) or dexamethasone-treated (B) P4 pups. Boxed regions in A and B are enlarged in C and D, and E, respectively. C and D: VE-cadherin (red)–stained zippers
in tips of lymphatic sprouts (C: arrows) and primitive buttons in other portions (D: arrows) of initial lymphatics from untreated trachea. E: After dexamethasone,
oak leaf–shaped endothelial cells have buttons (arrows) with a complementary distribution with LYVE-1 (green) at cell borders. F and G: Zippers (arrows) in
collecting lymphatics containing intraluminal valves from untreated (F) and dexamethasone-treated (G) mice. H and I: Jagged zipper-like junctions (arrows) in
thoracic ducts of untreated (H) and dexamethasone-treated (I) mice. Scale bars: 100 m (A and B); 50 m (F and G); 20 m (C–E and H–I).
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tions, when few zippers were still present.
The transformation of zippers into buttons coincided
Figure 7. GR activation in lymphatics by dexamethasone at P4. A–F: Confoca
littermates treated with dexamethasone from P0 to P4 (C, D, and F). Endothelia
nuclear Prox1 (blue). A and B: Nuclear phospho-GR Ser211 is expressed in alm
Prox1 (red, arrows). C and D: After dexamethasone, nuclear phospho-GR Ser2
colocalization with Prox1 in nuclei (D: purple, arrows). E and F: Negative conwith changes in the shape of lymphatic endothelial cellsfrom spindle to oak leaf and in the distribution of LYVE-1
during development. At E16.5 and earlier, LYVE-1 was
uniformly distributed in lymphatics. Most of the transfor-
of lymphatics in tracheal whole mounts of untreated P4 pups (A, B, and E) or
ctions stained for VE-cadherin (green), nuclear phospho-GR Ser211 (red), and
cell in untreated trachea but is weak in lymphatic endothelial cells marked by
ng in lymphatic endothelial cells is stronger and more widespread, as shown by
mary antibody for phospho-GR Ser211 was omitted). Scale bar  20 m.l images
l cell jun
ost everymation into the adult pattern, in which LYVE-1 is concen-
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curred from P0 to P28. LYVE-1, which is thought to be
involved in hyaluronan homeostasis,49 is one of the ear-
liest markers expressed in lymphatics50 and becomes
largely restricted to initial lymphatics during lymphatic
maturation.51,52 The involvement of LYVE-1 in lymphatic
function is, however, still uncertain because LYVE-1–null
mice lack any apparent lymphatic abnormalities.53,54
Despite their structural differences, the same junctional
proteins found in newly formed buttons were already pres-
ent in zippers before the buttons formed. In both buttons
and zippers, VE-cadherin was present in adherens junc-
tions, and occludin, claudin-5, ZO-1, junctional adhesion
molecule-A, and endothelial cell–selective adhesion mole-
cule were present in tight junctions.20,21 This finding sug-
gests that the stepwise recruitment of proteins is not
necessary for transformation of zippers into buttons or
vice versa. Instead, the presence of intermediate forms of
junctions during development could reflect a process of
junctional maturation involving the redistribution of junc-
tional proteins in the cell membrane.
The forces involved in the transformation of zippers into
buttons are unclear, but the coincidence with birth is an
important clue, because of the need for efficient clearance
of amniotic fluid from the lungs after the onset of breathing.
The importance of lymphatics in this process is evident from
genetically engineered mice, in which development of lung
lymphatics is suppressed by lung-specific overexpression
of VEGFR-3 ectodomains that trap VEGF-C and VEGF-D.
These mice have impaired lung fluid clearance and dimin-
ished survival after birth.37 Hydraulic forces have pro-
nounced effects on blood vessel remodeling in develop-
ment,55 and lymph flow influences fluid and cell transport
functions of the lymphatic endothelium.56
The observation that most Prox1-positive cells were
interconnected by junctions at E12.5 deserves further
study, because lung lymphatics may form from single
endothelial cells that migrate into lung parenchyma in-
stead of from sprouting from other lymphatics.37 Lymp-
hangiogenesis could play a more important role at this
stage than migration of single lymphatic endothelial cells.
Changes in Lymphatic Endothelial Cell
Junctions in Airway Inflammation and Resolution
AfterM. pulmonis infection, lymphatic sprouts are evident
at 7 days. The endothelium of the new vessels has zip-
pers instead of buttons. By 14 days, the existing lymphat-
ics, identified by their location between cartilage rings,
also have zippers where buttons are normally located.
The finding that zippers replaced buttons in lymphatics
in sustained inflammation raises the possibility that junc-
tional alterations contribute to impaired fluid clearance
and mucosal edema. If so, the reversal by dexametha-
sone of the zipper-to-button conversion and restoration of
the oak leaf shape of lymphatic endothelial cells could
improve fluid clearance and contribute to the beneficial
effects of the steroid.
Additional studies will be needed to ascertain that but-
tons, and the flaps and openings between them, are com-ponents of the primary valves and that junctional changes in
inflamed lymphatic endothelial cells lead to impaired fluid
entry and edema. Although quantitative studies that have
taught so much about lymphatic function in sheep and
dogs57 are much more challenging in mice, technological
advances are likely to make this possible.23,58,59
Like dexamethasone, inhibition of VEGFR-3 signaling by
antibody mF4-31C1 stopped further lymphangiogenesis af-
ter M. pulmonis infection, but unlike steroid treatment,
VEGFR-3 blockade did not promote button formation. Al-
though VEGFR-3 signaling is necessary and sufficient for
lymphangiogenesis after the infection,29 it was not required
for the conversion of buttons into zippers.
Dynamics of Cell Junctions
Intercellular junctions are not static structures but can
change under physiological and pathological conditions.
The present understanding of the development and mat-
uration of cell junctions is based largely on studies of
epithelial and vascular endothelial cells, in which the
integrity and barrier function of the layer is maintained by
the number and distribution of adherens and tight junc-
tions. In both cell types, adherens junctions form first in
development and may regulate the subsequent assem-
bly of tight junctions to form the barrier.60–62
Junctional dynamics have been extensively studied in
the intestinal epithelium, where changes occur normally
for absorption and in disease.63,64 The presence of para-
cellular openings in the airway epithelium allows fluid and
cell movement from the tissue into the lumen without
influencing the epithelial cell integrity.65,66 Junctional
changes have also been proposed for primary valves of
initial lymphatics, to explain the opening and closing dur-
ing maintenance of tissue fluid homeostasis.12 However,
evidence that the primary valves are flap-covered, junc-
tionless openings flanked by buttons argues that fluid
and cell entry can occur without junctional remodeling,
because the openings are always present.20
Junctional changes in the endothelium of blood vessels
are well-documented features of inflammation. Many inflam-
matory mediators cause plasma leakage by triggering the
formation of intercellular gaps between endothelial cells of
venules.27,67,68 In addition to the reorganization of junctional
proteins, phosphorylation of VE-cadherin can weaken inter-
cellular adhesion without apparent junctional rearrange-
ment, and changes in transmural driving force and modifi-
cations of the endothelial glycocalyx can also influence the
amount of plasma leakage in inflammation.61,69
Actin filament dynamics contribute to the stability and
barrier function of vascular endothelial cells.61,70–73 A
rearrangement of the junction-associated cortical actin cy-
toskeleton could also be involved in the reorganization of
the junctional proteins and LYVE-1 in lymphatic endothelial
cells. The colocalization of the actin-binding proteins
-catenin and ZO-1 at zippers and buttons fits with the
close relationship of the cytoskeleton and junctional pro-
teins and raises the possibility that actin rearrangements
could regulate the interconversion of buttons and zippers.
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Maturation in Postnatal Development
Buttons were more abundant in neonates at age P4 after
dexamethasone treatment than in age-matched controls.
The promotion of button formation by dexamethasone in
neonatal lymphatics was in the absence of inflammation,
consistent with a steroid action beyond that of simply
reducing the inflammatory response. Dexamethasone
can improve the barrier function of tight and adherens
junctions in cultured cells through effects on -catenin
and VE-cadherin.74,75 The presence of phosphorylatedGR
in the nucleus of most cells indicates a baseline level of GR
signaling in neonatal airways. However, phospho-GR im-
munoreactivity was stronger in nuclei of lymphatic endothe-
lial cells after dexamethasone, consistent with direct effects
of the steroid on these cells. The coincidence of increased
GR activation and promotion of button formation after dexa-
methasone suggests a link between the two. Studies of GRs
and glucocorticoid-deficient mice have documented the
important role of GR signaling in lung development.76 For-
mal elucidation of the mechanism of action of dexametha-
sone on lymphatic cell junctions will require further study,
but the effects are beneficial.
In conclusion, intercellular junctions of lymphatic endothelial
cells are dynamic during development and sustained inflam-
mation. When lymphatics form during development, only zip-
pers are present. Buttons first appear in initial lymphatics
aroundbirth. Theconversionof zippers intobuttonsappears to
result from transformation of one junctional type into the other
via the formation of intermediate junctional forms. The reverse
occurs in sustained inflammation, in which both newly formed
and existing lymphatics have zippers but no buttons. Treat-
ment with dexamethasone can reverse the process and re-
store buttons in initial lymphatics. Dexamethasone can also
promote button formation in lymphatics during the neonatal
period in the absence of inflammation. The steroid increases
phosphorylated GRs in nuclei of lymphatic endothelial cells
and thus theeffects of dexamethasoneon lymphatics are likely
to be at least partly direct. Together, the findingsdocument the
plasticity of intercellular junctions in lymphatics and the poten-
tial for pharmacological manipulation. The precisely timed
remodeling of lymphatic junctions during prenatal and
postnatal development provides a model for identifying
factors that influence lymphatic barrier function and mat-
uration. Drugs that promote the transformation of zippers
into buttons have potential therapeutic significance for
ameliorating mucosal edema in inflammatory conditions
of the airways, lungs, and other organs.
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